Eton Pharmaceuticals (ETON) Operating Income (2018 - 2026)
Eton Pharmaceuticals (ETON) posted Operating Income of $2.5 million for Q4 2025, up 280.78% sequentially from -$1.4 million in Q3 2025, and up 291.73% YoY from $629000.0 in Q4 2024.
Eton Pharmaceuticals (ETON) Operating Income (2018 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Operating Income for 8 years, with the latest figure at $2.5 million in Q4 2025.
- Quarterly Operating Income rose 291.73% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$844000.0 (up 67.5% YoY) and the FY2025 annual result came in at -$844000.0, up 67.5% from the prior year.
- Operating Income grew to $2.5 million in Q4 2025 per ETON's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Operating Income peaked at $5.4 million in Q1 2021 and troughed at -$5.8 million in Q3 2021.
- A 5-year average of -$719400.0 and a median of -$1.1 million in 2022 frame the typical range for Operating Income.
- The sharpest annual moves came in 2023 and 2025: Operating Income jumped 389.78% in 2023, then sank 367.78% in 2025.
- Over 5 years, Operating Income stood at $1.3 million in 2021, then decreased by 19.18% to $1.1 million in 2022, then plunged by 287.66% to -$2.0 million in 2023, then soared by 131.56% to $629000.0 in 2024, then surged by 291.73% to $2.5 million in 2025.
- According to Business Quant data, Operating Income over the past three periods registered $2.5 million, -$1.4 million, and -$1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.66 Bn | 1.63 Bn | 25.41 Mn | 12.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.79 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | -470,000.00 |
| Dec 31, 2024 | 629,000.00 |
| Sep 30, 2024 | 509,000.00 |
| Jun 30, 2024 | -2.94 Mn |
| Mar 31, 2024 | -800,000.00 |
| Dec 31, 2023 | -1.99 Mn |
| Sep 30, 2023 | -548,000.00 |
| Jun 30, 2023 | 3.88 Mn |
| Mar 31, 2023 | -2.53 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | -2.90 Mn |
| Jun 30, 2022 | -1.34 Mn |
| Mar 31, 2022 | -5.09 Mn |
| Dec 31, 2021 | 1.31 Mn |
| Sep 30, 2021 | -5.85 Mn |
| Jun 30, 2021 | -2.33 Mn |